2nd Quarter - Report
VENN STRATEGIES for ELI LILLY AND COMPANY
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
General tax issues pertaining to Eli Lilly, including but not limited to tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NATASCHA CUMBERLIDGE | — |
| CLAIRE ONYECHI New | U.S. Senate, Office of the Democratic Leader, Democratic Steering and Outreach Committee |
| AUSTIN TYLER ROBERTS | — |
| STEPHANIE SILVERMAN | — |
| MICHAEL SPIRA | — |
Health Issues HCR
General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation and innovation policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NATASCHA CUMBERLIDGE | — |
| CLAIRE ONYECHI New | U.S. Senate, Office of the Democratic Leader, Democratic Steering and Outreach Committee |
| AUSTIN TYLER ROBERTS | — |
| STEPHANIE SILVERMAN | — |
| MICHAEL SPIRA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.